ZebiAI

In one of their first ever acquisitions, Relay bets $85M cash on a new AI-based screening approach
Endpoints
Fri, 04/16/21 - 09:51 am
Relay Therapeutics
M&A
ZebiAI
artificial intelligence
drug discovery